These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17135778)

  • 21. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
    Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
    J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.
    Fuchsjäger MH; Shukla-Dave A; Hricak H; Wang L; Touijer K; Donohue JF; Eastham JA; Kattan MW
    BJU Int; 2009 Aug; 104(3):315-20. PubMed ID: 19220263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features.
    Boccon-Gibod LM; Dumonceau O; Toublanc M; Ravery V; Boccon-Gibod LA
    Eur Urol; 2005 Dec; 48(6):895-9. PubMed ID: 16125298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens.
    Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO
    J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of minute adenocarcinomas of prostate at radical prostatectomy.
    Truskinovsky AM; Sanderson H; Epstein JI
    Urology; 2004 Oct; 64(4):733-7. PubMed ID: 15491711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
    Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathological prostate cancer characteristics at radical prostatectomy after population based screening.
    Hoedemaeker RF; Rietbergen JB; Kranse R; Schröder FH; van der Kwast TH
    J Urol; 2000 Aug; 164(2):411-5. PubMed ID: 10893598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI spectroscopy in screening of prostate cancer.
    Goeb K; Engehausen DG; Krause FS; Hollenbach HP; Niedobitek G; Buettner M; Frangou P; Engelhard K
    Anticancer Res; 2007; 27(1B):687-93. PubMed ID: 17348461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Gleason grade and score between preoperative biopsy and prostatectomy specimens in prostate cancer.
    Tomioka S; Nakatsu H; Suzuki N; Murakami S; Matsuzaki O; Shimazaki J
    Int J Urol; 2006 May; 13(5):555-9. PubMed ID: 16771725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens.
    Berger AP; Spranger R; Kofler K; Steiner H; Bartsch G; Horninger W
    Prostate; 2003 Oct; 57(2):93-8. PubMed ID: 12949932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings.
    Villers A; Puech P; Mouton D; Leroy X; Ballereau C; Lemaitre L
    J Urol; 2006 Dec; 176(6 Pt 1):2432-7. PubMed ID: 17085122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
    J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Does transrectal MRI before radical prostatectomy modify the operative technique to decrease the positive margin rate?].
    Descazeaud A; Peyromaure M; Vieillefond A; Bernard D; Zerbib M
    Prog Urol; 2006 Nov; 16(5):564-7. PubMed ID: 17175952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The diagnostic value of pre-biopsy magnetic resonance imaging for precise detection of clinically localized prostate cancer compared to post-biopsy setting].
    Takahashi M; Horiguchi A; Tasaki S; Kuroda K; Sato A; Asakuma J; Seguchi K; Hayakawa M; Ito K; Asano T; Tamura C; Shinmoto H
    Hinyokika Kiyo; 2013 Dec; 59(12):769-73. PubMed ID: 24419007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of multiparametric pelvic magnetic resonance imaging on risk stratification in patients with localized prostate cancer.
    Marcus DM; Rossi PJ; Nour SG; Jani AB
    Urology; 2014 Jul; 84(1):132-7. PubMed ID: 24785987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of MRI in minimally invasive focal ablative therapy for prostate cancer.
    Rosenkrantz AB; Scionti SM; Mendrinos S; Taneja SS
    AJR Am J Roentgenol; 2011 Jul; 197(1):W90-6. PubMed ID: 21701001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-time sonoelastography compared to magnetic resonance imaging using four different modalities at 3.0 T in the detection of prostate cancer: strength and weaknesses.
    Pelzer AE; Heinzelbecker J; Weiß C; Frühbauer D; Weidner AM; Kirchner M; Stroebel P; Schoenberg SO; Dinter DJ
    Eur J Radiol; 2013 May; 82(5):814-21. PubMed ID: 23273821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [EVALUATION OF DIAGNOSTIC SIGNIFICANCE OF PELVIC MRI IN PROSTATE CANCER PATIENTS].
    Rasner PI; Kotenko DV; Kolontarev KB; Brodeckij BM; Pushkar DY
    Urologiia; 2015; (1):44-8. PubMed ID: 26094386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.